Related references
Note: Only part of the references are listed.Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
Yuan Qian et al.
BIOMATERIALS (2016)
Supramolecular peptide vaccines: tuning adaptive immunity
Yi Wen et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
Priscilla N. Kelly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes
Jean L. Koff et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2015)
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma
Kui Shin Voo et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Consequences of the recurrent MYD88L265P somatic mutation for B cell tolerance
James Q. Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Toll-like receptors in the pathogenesis of human B cell malignancies
Johana M. Isaza-Correa et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2
Marian M. J. H. P. Willems et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
IRAK4 Dimerization and trans-Autophosphorylation Are Induced by Myddosome Assembly
Ryan Ferrao et al.
MOLECULAR CELL (2014)
Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment
Carlo Visco et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand-Peptide Conjugates
Gijs G. Zom et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Laura Jeanbart et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Toll-Like Receptor-4 Signaling in Mantle Cell Lymphoma Effects on Tumor Growth and Immune Evasion
Lijuan Wang et al.
CANCER (2013)
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
Bjoern Chapuy et al.
CANCER CELL (2013)
The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach
Andres J. M. Ferreri et al.
CURRENT OPINION IN ONCOLOGY (2013)
Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment
Rym Ben Abdelwahed et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival
Derrick D. Kao et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine
Anna Wolska et al.
LEUKEMIA & LYMPHOMA (2013)
Negative regulatory approaches to the attenuation of Toll-like receptor signaling
Muhammad Ayaz Anwar et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Imageable Antigen-Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo
In-Hyun Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Pathogenesis of Human B Cell Lymphomas
Arthur L. Shaffer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
EBV-associated lymphomas in adults
Mark Roschewski et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2012)
HIV-associated lymphoma
Lawrence D. Kaplan
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2012)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
A. Carvalho et al.
GENES AND IMMUNITY (2012)
BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas
Qingguo Yan et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
Barbara Drobits et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Elias Campo et al.
BLOOD (2011)
TLR based therapeutics
Aisling Dunne et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
TLR-2-Activated B Cells Suppress Helicobacter-Induced Preneoplastic Gastric Immunopathology by Inducing T Regulatory-1 Cells
Ayca Sayi et al.
JOURNAL OF IMMUNOLOGY (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappa B
Yang Xu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma
Thomas J. Smith et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Lympho-geographical concepts in vaccine delivery
Pal Johansen et al.
JOURNAL OF CONTROLLED RELEASE (2010)
TLR Ligation Triggers Somatic Hypermutation in Transitional B Cells Inducing the Generation of IgM Memory B Cells
Alaitz Aranburu et al.
JOURNAL OF IMMUNOLOGY (2010)
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
Xin An et al.
LEUKEMIA RESEARCH (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Using Functional Genetics to Understand Breast Cancer Biology
Alan Ashworth et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Expression and function of toll like receptors in chronic lymphocytic leukaemia cells
Marta Muzio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma
Mark P. Purdue et al.
CARCINOGENESIS (2009)
Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
John M. Kirkwood et al.
CLINICAL CANCER RESEARCH (2009)
Toll-Like Receptors and their Role in Hematologic Malignancies
Anna Wolska et al.
CURRENT MOLECULAR MEDICINE (2009)
Toll-like receptors - sentries in the B-cell response
Isabelle Bekeredjian-Ding et al.
IMMUNOLOGY (2009)
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity
Juan R. Cubillos-Ruiz et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Infectious agents and lymphoma development: molecular and clinical aspects
A. J. M. Ferreri et al.
JOURNAL OF INTERNAL MEDICINE (2009)
The role of Toll-like receptors in chronic B cell malignancies
Marta Muzio et al.
LEUKEMIA & LYMPHOMA (2009)
Toll-like receptors and cancer
Seth Rakoff-Nahoum et al.
NATURE REVIEWS CANCER (2009)
Toll-like receptors: lessons to learn from normal and malignant human B cells
David Chiron et al.
BLOOD (2008)
Bacterial targeted tumour therapy-dawn of a new era
Ming Q. Wei et al.
CANCER LETTERS (2008)
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Alexandar Tzankov et al.
HAEMATOLOGICA (2008)
IRAK-4-and MyD88-Dependent Pathways Are Essential for the Removal of Developing Autoreactive B Cells in Humans
Isabelle Isnardi et al.
IMMUNITY (2008)
Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins
Alexander Dalpke et al.
IMMUNOBIOLOGY (2008)
CpG drives human transitional B cells to terminal differentiation and production of natural antibodies
Federica Capolunghi et al.
JOURNAL OF IMMUNOLOGY (2008)
Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF
Weifeng Xu et al.
JOURNAL OF IMMUNOLOGY (2008)
TLR-activated B cells suppress T cell-mediated autoimmunity
Vicky Lampropoulou et al.
JOURNAL OF IMMUNOLOGY (2008)
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
A. M. Krieg
ONCOGENE (2008)
Gastric extranodal marginal zone B-cell lymphomas of MALT type exclusively express toll-like receptor 4 in contrast to other lymphomas infiltrating the stomach
P. Adam et al.
ANNALS OF ONCOLOGY (2008)
TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells
Tom A. Barr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells
Georg Stary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Toll-like receptors and innate immunity in B-cell activation and antibody responses
Antonio Lanzavecchia et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands
Isabelle Bekeredjian-Ding et al.
JOURNAL OF IMMUNOLOGY (2007)
Expression and function of Toll-like receptors in T lymphocytes
Dieter Kabelitz
CURRENT OPINION IN IMMUNOLOGY (2007)
Marginal-zone lymphoma
Andres J. M. Ferreri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk
A. Nieters et al.
GENES AND IMMUNITY (2006)
Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma
Brian K. Link et al.
JOURNAL OF IMMUNOTHERAPY (2006)
A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy
Yang Je Cho et al.
VACCINE (2006)
Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma
Matthew S. Forrest et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors
G Jego et al.
LEUKEMIA (2006)
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation
F Suarez et al.
BLOOD (2006)
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation
MA Weniger et al.
ONCOGENE (2006)
Toll-like receptor stimulation as a third signal required for activation of human naive B cells
CR Ruprecht et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptors, inflammation and cancer
MF Tsan
SEMINARS IN CANCER BIOLOGY (2006)
Immunomodulatory effects of toll-like receptor-7 activation on chronic lymphocytic leukemia cells
DE Spaner et al.
LEUKEMIA (2006)
Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia
SL Corthals et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Novel Toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors
V Damiano et al.
CLINICAL CANCER RESEARCH (2006)
Toll-like receptors mediate proliferation and survival of multiple myeloma cells
J Bohnhorst et al.
LEUKEMIA (2006)
Association study of a functional toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma
S Hellmig et al.
LEUKEMIA & LYMPHOMA (2005)
CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response
GSD Reid et al.
BLOOD (2005)
The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides
M Henault et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells
B Jahrsdörfer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides
B Jahrsdorfer et al.
CLINICAL CANCER RESEARCH (2005)
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011
JC Byrd et al.
BLOOD (2005)
Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help
H Poeck et al.
BLOOD (2004)
A toll-like receptor that prevents infection by uropathogenic bacteria
DK Zhang et al.
SCIENCE (2004)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas
C Kelaidi et al.
LEUKEMIA (2004)
CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10
B He et al.
JOURNAL OF IMMUNOLOGY (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
J Vollmer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles
L Arcaini et al.
CANCER (2004)
Modulating vaccine responses with dendritic cells and Toll-like receptors
B Pulendran
IMMUNOLOGICAL REVIEWS (2004)
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells
E Bourke et al.
BLOOD (2003)
A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells
NL Bernasconi et al.
BLOOD (2003)
TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology
H Wu et al.
BIOESSAYS (2003)
Rational approaches to human cancer immunotherapy
ID Davis et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
V Hornung et al.
JOURNAL OF IMMUNOLOGY (2002)
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
EA Leadbetter et al.
NATURE (2002)
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
H Hemmi et al.
NATURE IMMUNOLOGY (2002)
Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication
I Salam et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2001)
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
C Wang et al.
NATURE (2001)
Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells
TH Chuang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2001)
Regulation of Toll-like receptors in human monocytes and dendritic cells
A Visintin et al.
JOURNAL OF IMMUNOLOGY (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)
Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain
L Deng et al.
CELL (2000)
Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
M Muzio et al.
JOURNAL OF IMMUNOLOGY (2000)
Mechanism and function of a newly identified CpG DNA moth in human primary B cells
G Hartmann et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
